Horizon Discovery Sign Cancer Metabolomics Service Agreement with GlaxoSmithKline

News   Oct 29, 2009

 
Horizon Discovery Sign Cancer Metabolomics Service Agreement with GlaxoSmithKline
 
 
 

RELATED ARTICLES

How Brown Fat Keeps Us Warm

News

A new study examining the type of fat in our body that keeps us warm could point the way to treatments for obesity.

READ MORE

Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca

News

New programs added in respiratory and cardio-metabolic diseases.

READ MORE

Lunaphore and Vitro Sign Collaboration Agreement

News

Companies announce a collaboration agreement to develop In Situ Hybridization (ISH) protocols for RNA and DNA targets in tissue using reagents provided by Vitro on Lunaphore’s rapid autostaining platform.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy